Are SIII and SIRI effective biomarkers for predicting the presence of atrial fibrillation in patients with ischemic stroke?
SIII and SIRI are potential biomarkers for predicting atrial fibrillation and assessing prognosis in patients with ischemic stroke.
Our study suggests SIII and SIRI are convenient and effective measurements for predicting the presence of AF in patients with ischemic stroke. Moreover, they were correlated with increased financial burden and poor short-term prognosis in AF patients presenting with ischemic stroke.
Lin et al. (Sat,) studied this question.